CRP and arthritic joint disease: In conclusion, the present study shows that Betesil is well tolerated and displays superior efficacy in reducing pain and functional disability and ameliorating CRP levels, redness, and edema, when compared with diclofenac sodium cream, in patients affected by arthritis and OA.